Recent Treatment Methods and their Efficacy for Corona Pandemic Situation
Abstract
Keywords
Full Text:
PDFReferences
Coronavirus Drug and Treatment Tracker New york times (October 4,2020) (https://www.nytimes.com/interactive/2020/science/coronavirus-drugs-treatments.html)
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus for picture
Remdesivir for the Treatment of Covid-19 — Preliminary Report (https://www.nejm.org/doi/full/10.1056/NEJMoa2007764)
Remdesivir, a remedy or a ripple in severe COVID-19 (https://www.tandfonline.com/doi/full/10.1080/13543784.2020.1821645?scroll=top&needAccess=true)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.(Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?) (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264155/)
Remdisivir (litcovid) (https://www.ncbi.nlm.nih.gov/research/coronavirus/publication/32401466)
Micronotes(https://microbenotes.com/favipiravir/)
Technology networks(April 02 , 2020) (https://www.technologynetworks.com/drug-discovery/news/phase-2-clinical-trial-of-apn01-for-treatment-of-covid-19-inititated-332897)
The lancet respiratory medicine ,(September 24)( https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30418-5/fulltext)
Ivermectin: potential candidate for the treatment of Covid 19(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321032/)
Ivermectin Could Turn COVID-19 Around. We Need To Find Out If It Works(trialsitenews) oct 1(https://www.trialsitenews.com/ivermectin-could-turn-covid-19-around-we-need-to-find-out-if-it-works/)
Ivermectin,oral drug.(medicalnewstoday) https://www.medicalnewstoday.com/articles/ivermectin-oral-tablhttps://www.medicalnewstoday.com/articles/ivermectin-oral-tabletets
DISulfiram for COvid-19 (DISCO) Trial (DISCO) (https://clinicaltrials.gov/ct2/show/NCT04485130)
WEBMD(https://www.webmd.com/drugs/2/drug-1446/disulfiram-oral/details)
Wikipedia(https://en.wikipedia.org/wiki/MK-4482#cite_note-pmid31945316-2)
EIDD-2801 shows efficacy against COVID-19 in human cells and mice(drug target) (https://www.drugtargetreview.com/news/59567/eidd-2801-shows-efficacy-against-covid-19-in-human-cells-and-mice/)
Clinical Trial Evaluating Oral Drug against Coronavirus Expected to Start Later This Spring (Genetic engineering and biotechnology news. April 8) (https://www.genengnews.com/news/clinical-trial-evaluating-oral-drug-against-coronavirus-expected-to-start-later-this-spring/)
The convalescent sera option for containing COVID-19(the journal of clinical investigation)( https://www.jci.org/articles/view/138003)
Can convalescent plasma therapy help treat the corona virus disease(Hindustan times) April 19 2020 (https://www.hindustantimes.com/analysis/use-technology-to-improve-governance/story-suvMkrNUIETDsA2ghdJRPM.html)
Treatment of Immunocompromised COVID‐19 patients with Convalescent Plasma(treatment infious disease)( https://onlinelibrary.wiley.com/doi/abs/10.1111/tid.13477)
Challenges of Convalescent Plasma Therapy on COVID 19 Qian Zhao and Yong He* (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146649/)
Clinical trials of monoclonal antibodies to prevent COVID-19 now enrolling (https://www.nih.gov/news-events/news-releases/clinical-trials-monoclonal-antibodies-prevent-covid-19-now-enrolling)
Eli Lilly reports promising first results for an antibody against COVID-19(Eli Lily) September 16,2020 (https://www.sciencemag.org/news/2020/09/eli-lilly-reports-first-promising-results-antibody-against-covid-19)
Antibodies made in the lab show some promise for treating COVID-1(sciencenews) (https://www.sciencenews.org/article/covid-19-coronavirus-antibodies-lab-treatment-immune-system)
AstraZeneca Begins Phase 1 Trial for Monoclonal Antibody Combination for COVID-19 (https://www.contagionlive.com/view/astrazeneca-begins-phase-1-trial-for-monoclonal-antibody-combination-for-covid19)
Drug vignettes: Interferons (https://www.cebm.net/covid-19/drug-vignettes-interferons/)
Interferons in the Therapy of Severe Coronavirus Infections: A Critical Analysis and Recollection of a Forgotten Therapeutic Regimen with Interferon Beta (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366041/)
Interferons (Alfa, Beta)NIH August 27 (https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/immunomodulators/interferons/)
Benefits and risks of interferon therapy for hepatitis B (https://aasldpubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.22956)
Tocilizumab (Actemra®) in COVID-19 Treatment (https://www.assaygenie.com/tocilizumab-actemra-in-covid19)
Kevzara (Sarilumab), a New IL-6 Receptor Antagonist, Approved for Active Rheumatoid Arthritis (http://www.ahdbonline.com/issues/2018/april-2018-vol-11-ninth-annual-payers-guide/2546-kevzara-sarilumab-a-new-il-6-receptor-antagonist-approved-for-active-rheumatoid-arthritis)
Mechanism of Action Sylvant siltuximab (https://www.sylvant.com/hcp/mechanism-of-action.html)
IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy? (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292936/)
Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19 (https://clinowl.com/interleukin-6-blocking-vs-jak-stat-inhibition-for-prevention-of-lung-injury-in-patients-with-covid-19/)
Expert recommendations on blood purification treatment protocol for patients with severe COVID-19 (https://www.sciencedirect.com/science/article/pii/S2095882X20300372)
Coronavirus Disease 2019 (COVID-19) Treatment & Management (https://emedicine.medscape.com/article/2500114-treatment#d20)
Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19) (https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-02020-3#citeas)
Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395577/)
Stem cell therapy for COVID‐19: Possibilities and challenges (https://onlinelibrary.wiley.com/doi/full/10.1002/cbin.11440)
Dexamethasone nanomedicines for COVID-19(nature nanotechnology) (https://www.nature.com/articles/s41565-020-0752-z)
COVID-19: What Is Dexamethasone and How Does It Work? (https://www.bbc.com/news/health-53077879)
Dexamethasone- Properties, uses, side effects & COVID-19 microbe notes (https://microbenotes.com/dexamethasone/)
Treatment of ARDS With Prone Positioning. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026253/)
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study (https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30268-X/fulltext#articleInformation)
The Down Side of Prone Positioning: The Case of a COVID-19 Survivor (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375183/)
Study shows anticoagulation therapy beneficial for COVID-19 patients (https://www.europeanpharmaceuticalreview.com/news/126922/study-shows-anticoagulation-therapy-beneficial-for-covid-19-patients/)
Anticoagulation in COVID-19 (cardiovascular pharmacotherapy) (https://academic.oup.com/ehjcvp/article/6/4/260/5827239)
Perceived advantages and disadvantages of oral anticoagulants, and the trade-offs patients make in choosing anticoagulant therapy and adhering to their drug regimen (https://www.sciencedirect.com/science/article/pii/S0738399118303197)
The prophylaxis and treatment potential of supplements for COVID-19 (https://www.sciencedirect.com/science/article/pii/S0014299920306221)
The Major Harmful Side Effects of Drinking Bleach (https://www.healthline.com/health/drinking-bleach)
Miracle Mineral Supplement (Wikipedia) (https://en.wikipedia.org/wiki/Miracle_Mineral_Supplement)
Ultraviolet radiation (WHO) (https://www.who.int/uv/health/solaruvrad.pdf)
Coronavirus disease (COVID-19) advice for the public: Mythbusters (WHO) (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters)
UV Lights and Lamps: Ultraviolet-C Radiation, Disinfection, and Coronavirus (https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/uv-lights-and-lamps-ultraviolet-c-radiation-disinfection-and-coronavirus )
Colloidal Silver https://www.nccih.nih.gov/health/colloidal-silver?fbclid=IwAR3UqQkkfRIbNP463MpZyfuc-KZlNueJfYsZcE1P-FcFhBAWE_Z3Hrn801k
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104368/)
Chinese official says Fujifilm’s Favipiravir could treat Covid-19(https://www.pharmaceutical-technology.com/news/fujifilm-favipiravir-covid-19/)
Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication (https://www.nature.com/articles/s41401-020-0430-6)
Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects(https://link.springer.com/article/10.1007%2Fs40262-013-0072-7)
Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model.( https://www.translationalres.com/article/S1931-5244(19)30256-7/fulltext)
Recommendations for Investigational COVID-19 Convalescent Plasma (https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma)
Monoclonal Antibodies for the Coronavirus (https://blogs.sciencemag.org/pipeline/archives/2020/04/27/monoclonal-antibodies-for-the-coronavirus)
Summary of advantages and disadvantages of current cell purification techniques (Summary of advantages and disadvantages of current cell purification techniques)
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial (https://www.nature.com/articles/s41392-020-00286-5#citeas)
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report (https://www.nejm.org/doi/full/10.1056/NEJMoa2021436#:~:text=The%20RECOVERY%20trial%20provides%20evidence,who%20did%20not%20require%20oxygen.)
Awake prone positioning for non-intubated oxygen dependent COVID-19 pneumonia patients. (https://erj.ersjournals.com/content/56/1/2001198)
Prone positioning in non-intubated patients with COVID-19: raising the bar (https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30269-1/fulltext)
Anticoagulant Therapy For Patients With Coronavirus Disease 2019: Urgent Need For Enhanced Awareness (https://www.ecrjournal.com/articles/Anticoagulant-Therapy-Coronavirus-COVID19?fbclid=IwAR3HvgVWmCo3mHLJrDvXlZOzc9FIIbNS86ZnPRYlRHoLazLpn7T5yuZI060)
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305763/)
Anticoagulant medicines (https://www.nhs.uk/conditions/anticoagulants/)
Disulfiram inhibits inflammatory gatekeeper protein—could it be helpful in COVID-19?
A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19 (https://www.dovepress.com/a-review-on-remdesivir-a-possible-promising-agent-for-the-treatment-of-peer-reviewed-fulltext-article-DDDT)
Favipiravir- properties, uses, mechanism, side effects, COVID-19 (Favipiravir- properties, uses, mechanism, side effects, COVID-19)
Prone Positioning. (https://relief.unboundmedicine.com/relief/view/CoRespond-Emerging-Topics/2425034/all/Prone_Positioning)
Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment (https://www.frontiersin.org/articles/10.3389/fimmu.2020.01563/full)
Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper (https://www.frontiersin.org/articles/10.3389/fimmu.2020.01648/full)
Novel Adjunctive Therapies for the Treatment of Tuberculosis (https://www.researchgate.net/figure/Fig-3-Mechanism-of-action-of-corticosteroids-Corticosteroids-diffuse-across-the-cell_fig1_258631989 )
Passive antibody therapy in COVID-19 (https://www.nature.com/articles/s41577-020-0365-7)
Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy (https://www.ajemjournal.com/article/S0735-6757(20)30465-4/fulltext)
Blockade of SARS-CoV-2 infection by recombinant soluble ACE2 (https://www.kidney-international.org/article/S0085-2538(20)30401-4/fulltext)
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons (https://www.sciencedirect.com/science/article/pii/S1359610120300708)
The Role of Anticoagulation in COVID-19-Induced Hypercoagulability (https://link.springer.com/article/10.1007/s11886-020-01328-8)
Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? (https://www.sciencedirect.com/science/article/pii/S0378512220303467)
The secret history of the first coronavirus https://www.forbes.com/sites/alexknapp/2020/04/11/the-secret-history-of-the-first-coronavirus-229e/#654dc40471d6
Coronavirus History (https://www.webmd.com/lung/coronavirus-history?fbclid=IwAR0N0f6xoCUAtME_th2Koy4X_1-QdaW3gfmSXmZdiFpu7BE2a5-QuODPf54#:~:text=Scientists%20first%20identified%20a%20human,Seven%20coronaviruses%20can%20infect%20humans)
Cell entry mechanisms of SARS-CoV-2 (https://www.pnas.org/content/117/21/11727?fbclid=IwAR1eWWBpxTl-pZ4ovpcnyg06blO2JaXVs2N6_l7ihPPRrCATbFsP2jB0T1c#:~:text=To%20enter%20host%20cells%2C%20coronaviruses,1%20B%20and%20C)
DOI: http://dx.doi.org/10.52155/ijpsat.v23.1.2250
Refbacks
Copyright (c) 2020 ayman bin mannan, Halima Habib

This work is licensed under a Creative Commons Attribution 4.0 International License.